Market Trends of North America Medical Aesthetic Devices Industry
Botulinum Toxin Segment is Expected to Register High Growth During the Forecast Period
Botulinum toxin is a neurotoxic protein produced by the bacterium clostridium botulinum. The botulinum toxin injections tend to block the nerve signals to the muscle in which it is injected. As the muscle cannot contract without a signal, it diminishes or decreases unwanted facial wrinkles or appearance. As a result, highly diluted concentrations of botulinum toxin are used for cosmetic and non-cosmetic purposes, such as for treating frown lines between the eyebrows, dystonia, chronic migraine, and other purposes.
For Instance, according to The American Society of Plastic Surgeons, a survey was released in June 2022 in the United States. It has been mentioned that botulinum toxin Type A is one of the top minimally invasive cosmetic procedures among patients during 2021-2022. It also reported that patients aged 31- 45 years most commonly seek botulinum toxin type A cosmetic procedures. Thereby, such factors are going to elevate the growth of the market.
Additionally, in September 2022, Revance Therapeutics Inc. received approval from USFDA approved DAXXIFY (Daxibotulinumtoxin-A-lanm) for injection for the temporary improvement of moderate to severe frown lines (glabellar lines) in adults. Thereby, such developments are elevating the segment, thereby elevating the market growth.
Therefore, the botulinum toxin segment is expected to witness significant growth over the forecast period due to the abovementioned factors.
United States Holds Significant Share and Expected to do the Same During the Forecast Period
The United States is expected to witness significant growth in the market owing to factors such as the increasing volume of different aesthetic procedures, rising awareness about aesthetic and minimally invasive procedures, and technological advancement in the country are expected to project significant growth.
According to the Aesthetic Society, 2021, it has been stated that the number of dermal filler procedures was around 1,857,339, which is around 32%, within the United States. Thereby, as most people are preferring to undergo such procedures the demand of the market is increasing.
For instance, according to the AAFPRS survey released in March 2022, an estimated 1.4 million surgical and non-surgical procedures were performed in the United States in 2021, an increase of 40% over the procedures performed in 2020. Additionally, according to the ISAPS survey released in December 2021, 860,718 aesthetic procedures were performed in Mexico in 2021, of which 456,489 were aesthetic surgical procedures and 404,229 were non-surgical aesthetic procedures. Thus, the increasing number of cosmetic procedures among the population is anticipated to boost the growth of the market during the forecast period.
Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the United States.
